Physician profile
Baylee Clark
NPI 1417728957
$3,793.74
in general payments reported to CMS, 2019-2025
44 companies · $3,084 in 2025
The $3,084 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $710 · 2025: $3,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,694 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,693.75 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $616.35 | 2024-2025 | Erleada, Talvey, Darzalex |
| Merck Sharp & Dohme LLC | $331.47 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Novartis Pharmaceuticals Corporation | $265.65 | 2025 | |
| Abbvie INC. | $243.24 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $176.07 | 2024-2025 | |
| Incyte Corporation | $157.91 | 2025 | Monjuvi, Jakafi, Pemazyre |
| Astrazeneca Pharmaceuticals LP | $154.04 | 2025 | Calquence, Enhertu |
| Glaxosmithkline, LLC. | $148.09 | 2025 | Jemperli, Ojjaara, Zejula |
| C. R. Bard, INC. & Subsidiaries | $124.94 | 2024-2025 | Bard Urinary Drainage Bag |
| Tersera Therapeutics LLC | $103.57 | 2025 | Zoladex |
| Seagen INC. | $99.99 | 2025 | |
| Sumitomo Pharma America, INC. | $86.95 | 2024-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $82.03 | 2025 | |
| Taiho Oncology, INC. | $78.59 | 2025 | |
| Caris Mpi, INC. | $78.14 | 2025 | Mi Cancer Seek |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baylee Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.